Your browser doesn't support javascript.
loading
The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma.
Fan, Huihsou; Yan, Wenqiang; Li, Lingna; Xu, Jingyu; Liu, Jiahui; Xu, Yan; Sui, Weiwei; Deng, Shuhui; Du, Chenxing; Yi, Shuhua; Zou, Dehui; Qiu, Lugui; An, Gang.
Afiliación
  • Fan H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • Yan W; Department of Hematology, The Affiliated Hospital of Qingdao University, Shandong, China.
  • Li L; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
  • Xu J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • Liu J; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
  • Xu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • Sui W; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
  • Deng S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • Du C; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
  • Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • Zou D; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
  • Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, People's Republic of Chin
  • An G; Tianjin Institutes of Health Science, Tianjin, People's Republic of China.
Hematology ; 28(1): 2182156, 2023 Dec.
Article en En | MEDLINE | ID: mdl-36815749
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hematology Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Hematology Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article